News ArchivesRead News
Parkinson's treated with Victorian era device
Tuesday April 24, 2012
Science a Go Go - A 19th century "vibration chair" has been found by Rush University researchers to significantly improve some of the symptoms of Parkinson's disease. The chair was designed by French anatomist Jean-Martin Charcot (pictured), who is often referred to as the father of modern day neurology. At the time, Charcot reported improvements in his patients, but he died before more complete evaluations could be completed. The Rush researchers set out to replicate his work to see if his claims hold true against modern scientific testing.
Charcot originally noted that his patients reported that during long carriage rides or train journeys, the uncomfortable or painful symptoms of Parkinson's disease seemed to disappear, and the relief lasted quite some time after the journey. Acting on these anecdotes, he developed a chair that mimicked the continuous jerking of a carriage or train.
For the modern day assessment, lead researcher Christopher G. Goetz randomly assigned 23 patients to either a vibrating chair or the same chair without vibration. During the treatment sessions, both groups of study participants listened to a relaxation CD of nature sounds. The study participants underwent daily treatment for a month. "We attempted to mimic Charcot's protocol with modern equipment in order to confirm or refute an historical observation," explained Goetz.
Reporting his findings in the Journal of Parkinson's Disease, Goetz noted that the patients in the vibration group showed significant improvement in motor function after daily 30-minute treatments. However, motor function scores for the no vibration group also improved significantly.
"Our results confirm Charcot's observation of improvement in Parkinson's disease with chronic vibration treatment, but we did not find the effect specific to vibration," said Goetz. "Instead, our data suggest that auditory sensory stimulation with relaxation in a lounge chair or simply the participation in a research protocol has equivalent benefit as vibration on motor function."
Despite the indication that the effect is due to placebo or other nonspecific factors, Goetz says the findings are still of value. "Our results will allow clinicians to guide patients to at least one apparatus that is safe and associated with objective changes in parkinsonian impairment scores," he concluded.
Recent NewsMay 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis
Apr 12 - Obstructive Sleep Apnea Affects Cognition in Parkinson's Disease
Apr 11 - Seattle boxing gym giving hope to Parkinson's patients
Apr 10 - A new rhythm
Apr 10 - Brain cells reprogrammed to make dopamine, with goal of Parkinson's therapy
Apr 6 - FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
Apr 5 - Combatting the isolation of young onset Parkinson's disease
Apr 1 - The Kid is Alright